CRL Nov 2024 280.000 call
| Previous Close | 25.00 |
| Open | 7.08 |
| Bid | 6.00 |
| Ask | 8.30 |
| Strike | 280.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 7.08 - 7.08 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
ZacksCharles River (CRL) Q1 Earnings & Revenues Beat, Fall Y/Y
Charles River's (CRL) Manufacturing and RMS business segments report organic revenue growth.
ZacksCharles River (CRL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Charles River (CRL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Reuters
Charles River beats first-quarter estimates, reaffirms annual forecast
Charles River Laboratories beat Wall Street estimates for first-quarter profit and revenue on Thursday, helped by strength in its manufacturing business and its unit that supplies research models to biotech clients. The contract research firm reaffirmed its full-year 2024 forecast, as it expects demand for its services to improve modestly during the second half of the year. Charles River and its peers have been grappling with weakening demand for their services due to a funding crunch among their biotech clients.
